Flu News Friday: May 2020
The Latest in Influenza Vaccines from May 2020
- A Model Approach
Lori Chordas, Best’s Review / June 2020
COVID-19 is shining a spotlight on the need for predictive infectious disease modeling to help insurers project the onset and spread of costly outbreaks. Years ago a model predicted that a universal influenza vaccine could reduce the risk of a novel flu pandemic outbreak by as much as 75%
- Universal coronavirus vaccines: the time to start is now
Luca T. Giurgea, Alison Han & Matthew J. Memoli , npj Vaccines /
May 28, 2010
Research into influenza immunity and vaccine development may provide valuable lessons for Covid-19 and may help guide vaccination strategies
- Structural transitions in influenza haemagglutinin at membrane fusion pH
Donald J. Benton, Steven J. Gamblin, Peter B. Rosenthal & John J. Skehel
Nature / May 27, 2020
- Chemical Engineering Professor Pursues Novel Methods of Treating Allergies, Flu
Amanda Bowman, Texas Tech Today / May 26, 2020
A profile of Harvinder Gill, the Whitacre Endowed Chair of Science and Engineering, and an associate professor of chemical engineering at Texas Tech University. From developing an immunotherapy to treat peanut allergies to trying to produce a universal flu vaccine, Gill’s use of microneedles and nanotechnology in his research is cutting edge.
- COVID-19 Damages Lungs Differently From the Flu: Study
Robert Preidt, US News & World Report / May 22, 2020
- How long can viruses survive in a dead body?
Medical XPress / May 21, 2020
Matt Koci, a virologist and immunologist whose work focuses on host-microbe interactions in birds answers some of the public’s burning questions about viruses and offers lessons we can learn from COVID-19.
“Stop waiting for nature to spit out a new strain and then rush to make a vaccine to it. We learned we really need a universal influenza vaccine, a vaccine that will provide protection to all strains of the flu no matter what nature decides to throw at us.”
- $1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine
David D. Kirkpatrick, New York Times / May 21, 2020
Barda will support drugmaker, AstraZeneca to develop a coronavirus vaccine candidate from Oxford University, lead by immunologist Sarah Gilbert. Prior to COVID-19 Gilbert was working to develop a universal influenza vaccine.
- How coronavirus lockdowns stopped flu in its tracks
Nicola Jones, Nature / May 21, 2020
- Pew’s Biomedical Community Continues to Push Scientific Boundaries
Kara Coleman & Jennifer Villa, PEW / May 12, 2020
Scholar highlight includes efforts for more accurate flu predictions and development of a universal influenza vaccine.
- Flu Vaccines Result from Global Collaboration: A COVID-19 Vaccine Will Too
Ayelet Haran, Global Trade Magazine / May 8, 2020
- Could the Flu Become History? An Israeli Vaccine May Make It a Reality
Anat Georgi & Sagi Cohen, Haaretz / May 6, 2020
The results of final clinical trials are due soon, capping two decades of work by Weizmann Institute Prof. Ruth Arnon and the startup BiondVax
- Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
BioSpace / May 6, 2020
Dr. Carter and his team are using another self-assembling protein called ferritin, a platform currently exploited by NIH in its exploration of the universal flu vaccine which completed phase I clinical trials earlier this year.
- Developing Covid vaccine is like flying a plane while trying to build it: University of Georgia’s Ted Ross
G Seetharaman, Economic Times / May 3, 2020
Influenza expert Ted Ross weighs in on the race to advance a COVID-19 vaccine and what methods his team is applying from their work in developing a universal influenza vaccine.
- Sumitomo Dainippon Pharma and National Institutes of Biomedical Innovation, Health and Nutrition (Japan) Conclude Joint Research Agreement for Universal Influenza Vaccine
Market Scanner / April 27, 2020